Reduced ADM and its receptors expression during pregnancy may play a role in promoting β-cell mass and insulin production, while increased plasma ADM in GDM may contribute to the β-cells dysfunction, and blockade of ADM may reverse β-cell insulin production. Here, INS is linked to gestational diabetes.